Clinical Trials Directory

Trials / Completed

CompletedNCT03618914

Anemia and Inflammation

Interactive Effects of Iron Status and Inflammation on Serum Hepcidin and Erythrocyte Iron Incorporation in Young Women

Status
Completed
Phase
Study type
Observational
Enrollment
50 (actual)
Sponsor
Swiss Federal Institute of Technology · Academic / Other
Sex
Female
Age
18 Years – 49 Years
Healthy volunteers
Accepted

Summary

During inflammation hepcidin concentrations are increased, leading to a decrease in iron absorption. In iron deficiency anemia hepcidin is suppressed due to the activation of erythropoiesis. Whether inflammation or anemia has the stronger effect on hepcidin is uncertain.

Conditions

Interventions

TypeNameDescription
BIOLOGICALDultavax and VaxigripAll the women got an influenza/DTP vaccine in order to induce acute inflammation

Timeline

Start date
2017-09-15
Primary completion
2018-03-29
Completion
2018-06-30
First posted
2018-08-07
Last updated
2018-08-22

Locations

1 site across 1 country: Morocco

Source: ClinicalTrials.gov record NCT03618914. Inclusion in this directory is not an endorsement.

Anemia and Inflammation (NCT03618914) · Clinical Trials Directory